nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—HTR2A—trigeminal nucleus—multiple sclerosis	0.127	0.246	CbGeAlD
Mesoridazine—HTR2A—trigeminal nerve—multiple sclerosis	0.0334	0.0645	CbGeAlD
Mesoridazine—HTR2A—pons—multiple sclerosis	0.0235	0.0454	CbGeAlD
Mesoridazine—DRD2—nerve—multiple sclerosis	0.0185	0.0357	CbGeAlD
Mesoridazine—HTR2A—pineal body—multiple sclerosis	0.0168	0.0324	CbGeAlD
Mesoridazine—HTR2A—peripheral nervous system—multiple sclerosis	0.0157	0.0302	CbGeAlD
Mesoridazine—HTR2A—nerve—multiple sclerosis	0.0122	0.0236	CbGeAlD
Mesoridazine—HTR2C—brainstem—multiple sclerosis	0.0105	0.0202	CbGeAlD
Mesoridazine—DRD3—nervous system—multiple sclerosis	0.00984	0.019	CbGeAlD
Mesoridazine—DRD3—central nervous system—multiple sclerosis	0.00948	0.0183	CbGeAlD
Mesoridazine—HTR6—nervous system—multiple sclerosis	0.00947	0.0183	CbGeAlD
Mesoridazine—HTR6—central nervous system—multiple sclerosis	0.00912	0.0176	CbGeAlD
Mesoridazine—HTR1A—brainstem—multiple sclerosis	0.0088	0.017	CbGeAlD
Mesoridazine—DRD2—brainstem—multiple sclerosis	0.00795	0.0153	CbGeAlD
Mesoridazine—DRD2—retina—multiple sclerosis	0.00767	0.0148	CbGeAlD
Mesoridazine—DRD3—brain—multiple sclerosis	0.00752	0.0145	CbGeAlD
Mesoridazine—HTR2C—medulla oblongata—multiple sclerosis	0.00729	0.0141	CbGeAlD
Mesoridazine—HTR6—brain—multiple sclerosis	0.00724	0.014	CbGeAlD
Mesoridazine—HTR2C—midbrain—multiple sclerosis	0.00666	0.0129	CbGeAlD
Mesoridazine—HTR2C—spinal cord—multiple sclerosis	0.0065	0.0125	CbGeAlD
Mesoridazine—CHRM2—nervous system—multiple sclerosis	0.00568	0.011	CbGeAlD
Mesoridazine—HTR1A—midbrain—multiple sclerosis	0.00561	0.0108	CbGeAlD
Mesoridazine—HTR2C—nervous system—multiple sclerosis	0.00548	0.0106	CbGeAlD
Mesoridazine—HTR1A—spinal cord—multiple sclerosis	0.00547	0.0106	CbGeAlD
Mesoridazine—CHRM2—central nervous system—multiple sclerosis	0.00547	0.0106	CbGeAlD
Mesoridazine—KCNH2—medulla oblongata—multiple sclerosis	0.00546	0.0105	CbGeAlD
Mesoridazine—HTR2C—central nervous system—multiple sclerosis	0.00527	0.0102	CbGeAlD
Mesoridazine—HTR2A—brainstem—multiple sclerosis	0.00524	0.0101	CbGeAlD
Mesoridazine—DRD2—midbrain—multiple sclerosis	0.00507	0.00978	CbGeAlD
Mesoridazine—HTR2A—retina—multiple sclerosis	0.00506	0.00976	CbGeAlD
Mesoridazine—KCNH2—midbrain—multiple sclerosis	0.00499	0.00963	CbGeAlD
Mesoridazine—KCNH2—spinal cord—multiple sclerosis	0.00487	0.0094	CbGeAlD
Mesoridazine—CYP2D6—brainstem—multiple sclerosis	0.00478	0.00922	CbGeAlD
Mesoridazine—HTR1A—nervous system—multiple sclerosis	0.00461	0.00889	CbGeAlD
Mesoridazine—HTR1A—central nervous system—multiple sclerosis	0.00444	0.00856	CbGeAlD
Mesoridazine—CHRM2—brain—multiple sclerosis	0.00434	0.00838	CbGeAlD
Mesoridazine—HTR1A—cerebellum—multiple sclerosis	0.00434	0.00837	CbGeAlD
Mesoridazine—HTR2C—brain—multiple sclerosis	0.00419	0.00808	CbGeAlD
Mesoridazine—DRD2—nervous system—multiple sclerosis	0.00416	0.00804	CbGeAlD
Mesoridazine—KCNH2—nervous system—multiple sclerosis	0.0041	0.00792	CbGeAlD
Mesoridazine—DRD2—central nervous system—multiple sclerosis	0.00401	0.00774	CbGeAlD
Mesoridazine—KCNH2—central nervous system—multiple sclerosis	0.00395	0.00762	CbGeAlD
Mesoridazine—DRD2—cerebellum—multiple sclerosis	0.00392	0.00756	CbGeAlD
Mesoridazine—KCNH2—cerebellum—multiple sclerosis	0.00386	0.00745	CbGeAlD
Mesoridazine—HTR2A—medulla oblongata—multiple sclerosis	0.00366	0.00705	CbGeAlD
Mesoridazine—HTR1A—brain—multiple sclerosis	0.00352	0.0068	CbGeAlD
Mesoridazine—HTR2A—midbrain—multiple sclerosis	0.00334	0.00645	CbGeAlD
Mesoridazine—HRH1—nervous system—multiple sclerosis	0.00329	0.00635	CbGeAlD
Mesoridazine—HTR2A—spinal cord—multiple sclerosis	0.00326	0.00629	CbGeAlD
Mesoridazine—DRD2—brain—multiple sclerosis	0.00318	0.00614	CbGeAlD
Mesoridazine—HRH1—central nervous system—multiple sclerosis	0.00317	0.00611	CbGeAlD
Mesoridazine—KCNH2—brain—multiple sclerosis	0.00314	0.00605	CbGeAlD
Mesoridazine—Ethopropazine—BCHE—multiple sclerosis	0.00298	0.279	CrCbGaD
Mesoridazine—HTR2A—nervous system—multiple sclerosis	0.00275	0.0053	CbGeAlD
Mesoridazine—HTR2A—central nervous system—multiple sclerosis	0.00264	0.0051	CbGeAlD
Mesoridazine—HTR2A—cerebellum—multiple sclerosis	0.00258	0.00499	CbGeAlD
Mesoridazine—HRH1—brain—multiple sclerosis	0.00251	0.00485	CbGeAlD
Mesoridazine—CYP2D6—nervous system—multiple sclerosis	0.0025	0.00483	CbGeAlD
Mesoridazine—Triflupromazine—BCHE—multiple sclerosis	0.00244	0.228	CrCbGaD
Mesoridazine—CYP2D6—central nervous system—multiple sclerosis	0.00241	0.00465	CbGeAlD
Mesoridazine—CYP2D6—cerebellum—multiple sclerosis	0.00235	0.00454	CbGeAlD
Mesoridazine—HTR2A—brain—multiple sclerosis	0.0021	0.00405	CbGeAlD
Mesoridazine—CYP2D6—brain—multiple sclerosis	0.00191	0.00369	CbGeAlD
Mesoridazine—Chlorpromazine—BCHE—multiple sclerosis	0.00118	0.11	CrCbGaD
Mesoridazine—Acepromazine—ALB—multiple sclerosis	0.000927	0.0867	CrCbGaD
Mesoridazine—Thioproperazine—ALB—multiple sclerosis	0.000906	0.0847	CrCbGaD
Mesoridazine—Pipotiazine—ALB—multiple sclerosis	0.000891	0.0834	CrCbGaD
Mesoridazine—Thiothixene—ALB—multiple sclerosis	0.000891	0.0834	CrCbGaD
Mesoridazine—Chlorpromazine—ALB—multiple sclerosis	0.000483	0.0452	CrCbGaD
Mesoridazine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000141	0.0003	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CD28—multiple sclerosis	0.000141	0.0003	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CD28—multiple sclerosis	0.00014	0.000298	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000139	0.000295	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	0.000139	0.000294	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	0.000138	0.000293	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CD86—multiple sclerosis	0.000136	0.000289	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—POMC—multiple sclerosis	0.000136	0.000288	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCL3—multiple sclerosis	0.000135	0.000286	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCL5—multiple sclerosis	0.000134	0.000284	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	0.000133	0.000282	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—CCL2—multiple sclerosis	0.000133	0.000282	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	0.000132	0.000281	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CXCL10—multiple sclerosis	0.000132	0.000281	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	0.000132	0.00028	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000131	0.000278	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	0.000131	0.000277	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	0.00013	0.000277	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	0.00013	0.000276	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	0.00013	0.000276	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—IL2—multiple sclerosis	0.00013	0.000276	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	0.00013	0.000275	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	0.000129	0.000275	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000129	0.000273	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000128	0.000273	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	0.000128	0.000272	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	0.000128	0.000272	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PGR—multiple sclerosis	0.000128	0.000271	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	0.000127	0.000271	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	0.000127	0.00027	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	0.000127	0.00027	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000126	0.000268	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PGR—multiple sclerosis	0.000126	0.000266	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PGR—multiple sclerosis	0.000125	0.000266	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	0.000125	0.000266	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	0.000125	0.000266	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—SPP1—multiple sclerosis	0.000124	0.000263	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CD28—multiple sclerosis	0.000124	0.000263	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	0.000123	0.000262	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	0.000123	0.000261	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	0.000123	0.000261	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CD28—multiple sclerosis	0.000122	0.000259	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCR2—multiple sclerosis	0.000122	0.000258	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CD28—multiple sclerosis	0.000122	0.000258	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	0.000121	0.000257	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCR5—multiple sclerosis	0.000121	0.000256	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—TYK2—multiple sclerosis	0.00012	0.000256	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	0.00012	0.000254	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	0.00012	0.000254	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	0.000119	0.000254	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL2RA—multiple sclerosis	0.000119	0.000252	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	0.000118	0.000251	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—IL2—multiple sclerosis	0.000118	0.000251	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	0.000118	0.00025	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	0.000118	0.00025	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	0.000116	0.000245	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CD86—multiple sclerosis	0.000116	0.000245	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	0.000115	0.000244	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	0.000115	0.000244	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	0.000115	0.000243	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	0.000114	0.000243	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCL5—multiple sclerosis	0.000114	0.000241	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	0.000112	0.000239	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CNR1—multiple sclerosis	0.000112	0.000238	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	0.000112	0.000238	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	0.000111	0.000235	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—IL2—multiple sclerosis	0.00011	0.000234	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	0.00011	0.000234	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	0.00011	0.000234	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—APOE—multiple sclerosis	0.00011	0.000233	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	0.000109	0.00023	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SPP1—multiple sclerosis	0.000105	0.000224	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	0.000105	0.000223	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	0.000104	0.000222	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—POMC—multiple sclerosis	0.000104	0.00022	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCR5—multiple sclerosis	0.000102	0.000218	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	0.000102	0.000217	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	0.000102	0.000216	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	0.000102	0.000215	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	0.000101	0.000215	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL2RA—multiple sclerosis	0.000101	0.000214	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CD86—multiple sclerosis	0.000101	0.000214	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL2—multiple sclerosis	0.0001	0.000213	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	0.0001	0.000213	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CD86—multiple sclerosis	0.0001	0.000213	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	9.99e-05	0.000212	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	9.97e-05	0.000212	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	9.95e-05	0.000211	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	9.93e-05	0.000211	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CD80—multiple sclerosis	9.93e-05	0.000211	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	9.91e-05	0.00021	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	9.86e-05	0.000209	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	9.81e-05	0.000208	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	9.77e-05	0.000207	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	9.62e-05	0.000204	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	9.57e-05	0.000203	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—POMC—multiple sclerosis	9.43e-05	0.0002	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—APOE—multiple sclerosis	9.32e-05	0.000198	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCL2—multiple sclerosis	9.23e-05	0.000196	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	9.22e-05	0.000196	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	9.18e-05	0.000195	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	9.14e-05	0.000194	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	9.07e-05	0.000193	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	9.05e-05	0.000192	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—MAPK1—multiple sclerosis	9.03e-05	0.000192	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	8.93e-05	0.00019	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	8.91e-05	0.000189	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	8.89e-05	0.000189	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CD86—multiple sclerosis	8.84e-05	0.000188	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	8.8e-05	0.000187	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	8.76e-05	0.000186	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	8.74e-05	0.000185	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	8.71e-05	0.000185	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	8.7e-05	0.000185	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	8.69e-05	0.000184	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CD86—multiple sclerosis	8.68e-05	0.000184	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	8.57e-05	0.000182	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	8.55e-05	0.000181	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	8.54e-05	0.000181	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	8.45e-05	0.000179	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CD80—multiple sclerosis	8.43e-05	0.000179	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	8.41e-05	0.000178	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TYK2—multiple sclerosis	8.38e-05	0.000178	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	8.31e-05	0.000176	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	8.29e-05	0.000176	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—BCHE—multiple sclerosis	8.27e-05	0.000176	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	8.16e-05	0.000173	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—APOE—multiple sclerosis	8.13e-05	0.000172	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	8.08e-05	0.000172	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	8.06e-05	0.000171	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—POMC—multiple sclerosis	8.01e-05	0.00017	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	7.93e-05	0.000168	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	7.92e-05	0.000168	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	7.84e-05	0.000166	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCL2—multiple sclerosis	7.84e-05	0.000166	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	7.79e-05	0.000165	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	7.73e-05	0.000164	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	7.72e-05	0.000164	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	7.7e-05	0.000163	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	7.67e-05	0.000163	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	7.67e-05	0.000163	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	7.61e-05	0.000161	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	7.59e-05	0.000161	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	7.58e-05	0.000161	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	7.55e-05	0.00016	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	7.53e-05	0.00016	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	7.47e-05	0.000158	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	7.41e-05	0.000157	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	7.35e-05	0.000156	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	7.31e-05	0.000155	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—APOE—multiple sclerosis	7.14e-05	0.000151	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TYK2—multiple sclerosis	7.12e-05	0.000151	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	7.02e-05	0.000149	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—APOE—multiple sclerosis	7.01e-05	0.000149	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	6.98e-05	0.000148	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL2—multiple sclerosis	6.97e-05	0.000148	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	6.95e-05	0.000147	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—IL6—multiple sclerosis	6.94e-05	0.000147	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	6.89e-05	0.000146	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	6.83e-05	0.000145	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	6.8e-05	0.000144	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	6.68e-05	0.000142	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	6.65e-05	0.000141	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MMP9—multiple sclerosis	6.6e-05	0.00014	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CD80—multiple sclerosis	6.45e-05	0.000137	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	6.35e-05	0.000135	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CD80—multiple sclerosis	6.33e-05	0.000134	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	6.23e-05	0.000132	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	6.2e-05	0.000132	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	6.17e-05	0.000131	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—POMC—multiple sclerosis	6.13e-05	0.00013	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	6.03e-05	0.000128	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—POMC—multiple sclerosis	6.02e-05	0.000128	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	6e-05	0.000127	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL2—multiple sclerosis	5.92e-05	0.000126	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	5.92e-05	0.000126	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	5.9e-05	0.000125	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL6—multiple sclerosis	5.89e-05	0.000125	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	5.89e-05	0.000125	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	5.87e-05	0.000125	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—STAT3—multiple sclerosis	5.87e-05	0.000125	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	5.79e-05	0.000123	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	5.77e-05	0.000123	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	5.76e-05	0.000122	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	5.67e-05	0.00012	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MMP9—multiple sclerosis	5.6e-05	0.000119	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MYC—multiple sclerosis	5.45e-05	0.000116	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	5.45e-05	0.000116	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	5.44e-05	0.000115	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	5.36e-05	0.000114	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	5.35e-05	0.000113	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	5.33e-05	0.000113	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	5.26e-05	0.000112	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	5.16e-05	0.00011	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	5.14e-05	0.000109	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	5.13e-05	0.000109	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	5.11e-05	0.000108	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—STAT3—multiple sclerosis	4.98e-05	0.000106	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOE—multiple sclerosis	4.98e-05	0.000106	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	4.88e-05	0.000104	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	4.86e-05	0.000103	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MYC—multiple sclerosis	4.63e-05	9.83e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	4.62e-05	9.8e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL2—multiple sclerosis	4.53e-05	9.62e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	4.53e-05	9.61e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	4.51e-05	9.57e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	4.46e-05	9.46e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL2—multiple sclerosis	4.45e-05	9.44e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	4.44e-05	9.42e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	4.43e-05	9.4e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	4.38e-05	9.29e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	4.36e-05	9.25e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	4.34e-05	9.22e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	4.32e-05	9.17e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	4.29e-05	9.1e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—POMC—multiple sclerosis	4.28e-05	9.08e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	4.22e-05	8.96e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	4.21e-05	8.94e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	4.14e-05	8.79e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL6—multiple sclerosis	4.1e-05	8.7e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	4.04e-05	8.57e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	4.03e-05	8.54e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	4.01e-05	8.52e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	4.01e-05	8.5e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	3.95e-05	8.38e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	3.93e-05	8.34e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ALB—multiple sclerosis	3.9e-05	8.27e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	3.81e-05	8.09e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	3.75e-05	7.96e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	3.74e-05	7.95e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	3.68e-05	7.82e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MYC—multiple sclerosis	3.54e-05	7.52e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	3.53e-05	7.5e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	3.49e-05	7.4e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL6—multiple sclerosis	3.48e-05	7.39e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MYC—multiple sclerosis	3.48e-05	7.38e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	3.48e-05	7.38e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	3.47e-05	7.37e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	3.47e-05	7.36e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	3.42e-05	7.27e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	3.41e-05	7.25e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	3.41e-05	7.24e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	3.4e-05	7.22e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	3.35e-05	7.11e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	3.03e-05	6.44e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	3.02e-05	6.41e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL6—multiple sclerosis	2.66e-05	5.65e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	2.62e-05	5.56e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL6—multiple sclerosis	2.62e-05	5.55e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.57e-05	5.46e-05	CbGpPWpGaD
